ETMarkets.comThe Rs 1,462-crore initial public offering (IPO) of Archean Chemical Industries received a decent response from investors during the second day of the bidding process. The issue was subscribed 45% on the first day.
The company is selling its shares in the range of Rs 387-407 apiece between November 9 to November 11, with a lot size of 36 equity shares.
According to the data from BSE, investors made bids for 98,86,680 equity shares or 50% compared to the 1,99,57,325 equity shares offered for subscription by 11.30 am on Thursday, November 10.
The quota for the retail bidders was subscribed 1.6 times, whereas the allocation for the HNI investors fetched 64% bids. The portion for the institutional investors was booked only 4% as of the given time.
Archean Chemical Industries has been India's largest exporter of bromine and industrial salt in fiscal year 2020-21. The company is the leading speciality marine chemical manufacturer in India.
Majority of the brokerage firms remain positive on the issue and have suggested subscribing to it. However, some have a word of caution citing expensive valuations.
The company has delivered 36.3% and 77.7% growth in revenue and EBITDA between FY20-22, respectively. The company is expected to utilize its funds for the redemption of NCDs issued by the company which will improve its debt-to-equity ratio, said Nirmal Bang Institutional Equities.
"This will have a positive impact on the profitability given the significant reduction in the interest cost of NCDs. It is valued at a discount based on its P/E of 26.6x, EV/EBITDA of 12.7x compared to its average valuation of peer companies," it added with a subscribe rating.
Archean Chemical Industries raised Rs 658 crore from anchor investors by allocating them 1,61,67,991 equity shares at Rs 407 apiece, according to the details available on BSE's website.
Being an export-oriented business with a strong client portfolio gives the company a competitive advantage over its peers. It also has an established infrastructure and integrated production has one of the largest salt works at a single location according to industry reports, said BP Equities.
"On the upper end of the price band, the issue is valued at a P/E of 22.3x based on FY22 consolidated earnings which we feel is fairly priced and hence initiate a ‘subscribe' rating to the IPO for the benefit of listing gains," it added.
However, Broking remains neutral on the company citing high competition from the international players and an increase in cost or shortfall of any raw material can impact business.
, and are the book running lead managers to the issue, whereas Link Intime India has been appointed as the registrar to the issue.
(Disclaimer: Recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of Economic Times)
The company is selling its shares in the range of Rs 387-407 apiece between November 9 to November 11, with a lot size of 36 equity shares.
According to the data from BSE, investors made bids for 98,86,680 equity shares or 50% compared to the 1,99,57,325 equity shares offered for subscription by 11.30 am on Thursday, November 10.
The quota for the retail bidders was subscribed 1.6 times, whereas the allocation for the HNI investors fetched 64% bids. The portion for the institutional investors was booked only 4% as of the given time.
Archean Chemical Industries has been India's largest exporter of bromine and industrial salt in fiscal year 2020-21. The company is the leading speciality marine chemical manufacturer in India.
Majority of the brokerage firms remain positive on the issue and have suggested subscribing to it. However, some have a word of caution citing expensive valuations.
The company has delivered 36.3% and 77.7% growth in revenue and EBITDA between FY20-22, respectively. The company is expected to utilize its funds for the redemption of NCDs issued by the company which will improve its debt-to-equity ratio, said Nirmal Bang Institutional Equities.
"This will have a positive impact on the profitability given the significant reduction in the interest cost of NCDs. It is valued at a discount based on its P/E of 26.6x, EV/EBITDA of 12.7x compared to its average valuation of peer companies," it added with a subscribe rating.
Archean Chemical Industries raised Rs 658 crore from anchor investors by allocating them 1,61,67,991 equity shares at Rs 407 apiece, according to the details available on BSE's website.
Being an export-oriented business with a strong client portfolio gives the company a competitive advantage over its peers. It also has an established infrastructure and integrated production has one of the largest salt works at a single location according to industry reports, said BP Equities.
"On the upper end of the price band, the issue is valued at a P/E of 22.3x based on FY22 consolidated earnings which we feel is fairly priced and hence initiate a ‘subscribe' rating to the IPO for the benefit of listing gains," it added.
However, Broking remains neutral on the company citing high competition from the international players and an increase in cost or shortfall of any raw material can impact business.
, and are the book running lead managers to the issue, whereas Link Intime India has been appointed as the registrar to the issue.
(Disclaimer: Recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of Economic Times)
Read More News on
(What's moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)
...moreDownload The Economic Times News App to get Daily Market Updates & Live Business News.
Pick the best stocks for yourself
Powered by